Professional Documents
Culture Documents
Nurs660 Therapeuticstable Agonzalez 1
Nurs660 Therapeuticstable Agonzalez 1
Page 1
Anne Gonzalez
The goal of treating the diabetic patient is to maintain tight glycemic control to prevent complications related to hyperglycemia. Medications
help control and maintain target glucose but there are also other methods of glycemic control. The patient will need to take action in physical activity,
mindful diet, and stress management; this will support and sustain glycemic balance (Faison, Burns, & Weed, 2016). The healthcare professional will
take into consideration the living environment, food insecurities, spiritual, psychological, and social life of each patient (Faison et al., 2016). Diabetes
requires the patient to participate in self-care and become responsible with the appropriate guidance (Potter, Wallston, Trief, Juth, & Smyth, 2015).
Medication is not a fix all but it is a start to help implement balance, but ultimately the intertwining wellbeing of mind, body and spirit (Potter et al.,
2015).
Name of Therapeutic
+Route
+Safe Dose [maximum
24hr dose; daily
dosing; onset/ peak/
duration]
Classification of
Therapeutic
[therapeutic and
pharmacologic OR
category of nonpharmacologic]
1. Metformin
(Glucophage)
Route: Oral
General Mechanism of
Action
[paraphrase in your own
words the physiologic
and/or psychological
basis for therapeutic
action using current
evidence]
General Mechanism of
Action
Metformin is the first
General Cost
of
Therapeutic
[per dose and
monthly cost]
Outline potential
contraindications for the
therapy
Page 2
General Cost
of
Therapeutic
References
[use in-text APA
style references
including
personal
communication
as appropriate]
References
(Adams,
Holland, &
Anne Gonzalez
antidiabetic medication
ordered to help with
hyperglycemia. This
medication decreases the
bodys insulin resistance
by increasing the
peripheral glucose
uptake. This is a
beneficial effect to
utilize the glucose
transporters to help
manage hyperglycemia.
unable to transport
glucose to cell for
metabolism. The cells
inability to transport
glucose is related to
increase lipid content in
the blood. Metformin
will help decrease the
amount of unused
glucose in the vascular
system.
Urban, 2014)
[per dose and
monthly cost]
Metformin
500mg: $0.23
per dose and
$6.99 per
month
(Cefalu, 2016)
(Fortney, 2012)
(Martin &
Talbert, 2013)
(Vallerand,
Sanoski, &
Deglin, 2015)
Anne Gonzalez
General Mechanism of
Action
Humalog insulin is a fast
acting insulin that
controls the metabolism
of glucose and will
stimulate glucose uptake
in muscles and adipose
tissue.
General Cost
of
Therapeutic
A 10ml vial of
Humalog cost
$272.00. A
10ml vial of
Humalog
contains
1000units.
Cost per unit
References
(Adams,
Holland, &
Urban, 2014)
(Cefalu, 2016)
(Fortney, 2012)
(Martin &
Anne Gonzalez
1.2 units/kg/da
Onset: within 15
minutes
Peak: one to two hours
Duration: three to four
Classification of
Therapeutic:
antidiabetic/
pancreatics
Talbert, 2013)
(Vallerand,
Sanoski, &
Deglin, 2015)
Anne Gonzalez
3. Lisinopril (Zestril)
Route: Oral
Safe dose in 24 hour
period: 40mg daily
Daily dosing: 2.5mg to
40mg daily
Onset: one hour
Peak: six hours
Duration: 24 hours
Classification of
Therapeutic:
Antihypertensive
General Mechanism of
Action
Lisinopril is considered
an angiotensinconverting enzyme
(ACE) inhibitor that
helps prevent
hypertension by stopping
angiotensin I from
becoming angiotensin II.
The increase in the levels
of plasma renin that is
excrete will prevent the
kidneys from retaining
fluid decrease the
volume of fluid in the
body therefore, dropping
blood pressure.
General Cost
of
Therapeutic:
Cost per dose
of Lisinopril
is $0.99 per
pill and
$29.70 for a
30-day supply.
References
(Adams,
Holland, &
Urban, 2014)
(Cefalu, 2016)
(Fortney, 2012)
(Martin &
Talbert, 2013)
(Vallerand,
Sanoski, &
Deglin, 2015)
Anne Gonzalez
4.Hydrochlorothiazide
Route: Oral
Safe dose in 24 hour
period:
Daily dosing: 50mg per
day
Onset: Two hours
Peak: Three to six
hours
Duration: Six to twelve
hours
Classification of
Therapeutic:
Antihypertensive
General Mechanism of
Action
HCTZ is a medication
that is a diuretic. It stops
the absorption of sodium
and water in the distal
tubuals of the kidneys.
This mechanism will
increase the patients
need to urinate. The
decreased volume of
fluid decreases the
patients blood pressure.
Outline potential
contraindication for the
therapy: Patient with end
stage renal disease should not
take this medication. An
individual with history of
hereditary angioedema can
develop an allergic reaction to
this medication.
Outline patient safety issues
associated with this therapy
Adverse Reactions: A
common adverse reaction to
HCTZ is hypotension,
hypokalemia, dizziness,
cramping and hyponatremia.
Drug-Drug Interaction:
HCTZ in conjunction with
other hypertensive therapies
can result in hypotension.
NSAIDs can decrease the
effectiveness of HCTZ.
Drug-Food Interaction:
Patients should be instructed
to eat food high in potassium
to prevent cramping, chest
pain and arrhythmias.
Outline potential
contraindication for the
therapy: Patients should be
assessed frequently for skin
Page 7
General Cost
of
Therapeutic
Monthly cost
for HCTZ is
$4.00 and cost
per dose daily
is $0.13.
References
(Adams,
Holland, &
Urban, 2014)
(Cefalu, 2016)
(Fortney, 2012)
(Martin &
Talbert, 2013)
(Vallerand,
Sanoski, &
Deglin, 2015)
Anne Gonzalez
General Mechanism of
Action
Lyrica is intended for
patients with peripheral
neuropathy. This
medication is a
nonopioid agent that
does not bind with
bodys opioid receptor.
This medication works
together with the central
nervous system, fusing
with calcium channel
blockers to monitor and
control neurotransmitter
interaction.
General Cost
of
Therapeutic
Cost of dose
for a 30-day
supply is
$369.42. Cost
per dose for
Lyrica is
$12.31.
References
(Adams,
Holland, &
Urban, 2014)
(Cefalu, 2016)
(Fortney, 2012)
(Joy, 2013)
(Martin &
Talbert, 2013)
(Vallerand,
Sanoski, &
Deglin, 2015)
Anne Gonzalez
6. Gabapentin
(Neurontin)
Route: Oral
Safe dose: 100mg oral
three times a day. This
medication can be
titrated weekly
300mg/day to 900 or
2400mg/day
Daily dosing in 24-hour
period: Titrate based on
pain. Maximum
allowed in a 24-hour
period is 3600mg.
Onset: Rapid
Peak: two to four hours
Duration: Eight hours
Classification of
Therapeutic:
Analgesic Adjuncts
General Mechanism of
Action
The action of mechanism
of this medication is
unknown. Research has
speculated it may effect
how amino acids are
transported and crossed
into the central nervous
system.
General Cost
of
Therapeutic
Cost for a
monthly
supply of
Gabapentin is
$42.92 and
per dose
$0.53.
References
(Adams,
Holland, &
Urban, 2014)
(Cefalu, 2016)
(Fortney, 2012)
(Joy, 2013)
(Martin &
Talbert, 2013)
(Vallerand,
Sanoski, &
Deglin, 2015)
Anne Gonzalez
7. Paxil
Route: Oral
Safe dose in 24 hour
period: 50mg
Daily dosing: Start
20mg and increase by
10mg daily maximum
dose is 50mg in a 24
hour period
Onset: one to four
weeks
Peak: unknown
Duration: unknown
Classification of
Therapeutic:
Antianxiety agent
Antidepressant
General Mechanism of
Action
Paxil is a selective
serotonin reuptake
inhibitor that blocks the
central nervous system
from reacting to the
serotonin.
General Cost
of
Therapeutic
Monthly cost
of Paxil
$173.61 and
cost per dose
is $5.78.
References
(Adams,
Holland, &
Urban, 2014)
(Cefalu, 2016)
(Fortney, 2012)
(Joy, 2013)
(Martin &
Talbert, 2013)
(Vallerand,
Sanoski, &
Deglin, 2015)
Anne Gonzalez
8. Lipitor
(Atorvastatin)
Route: Oral
Safe dose in 24 hour
period: Starting dose
10mg and increase to
80mg daily depending
on lipid fasting profile
Daily dosing: 10mg to
80mg daily
Onset: Unknown
Peak: Unknown
Duration: 20 to 30
hours
Classification of
Therapeutic: Lipid
Lowering Agent
General Mechanism of
Action
Lipitor is a medication
that will stop HMG-CoA
from communicating
with the liver. The lack
of communication will
prevent the liver from
producing cholesterol
and low-density lipids.
Vitamins to be avoided
include SAMe, Saint Johns
Wort, and tryptophan. These
vitamins can increase the
patients risk of developing
serotonin syndrome.
Outline potential
contraindication for the
therapy: Patients that are on a
MAO-inhibitor should not
take Paxil and stop Paxil or
MAO-inhibitor for at least
two weeks before starting new
medication therapy.
Outline patient safety issues
associated with this therapy
Adverse Reaction: Common
reported adverse reaction is
muscle weakness and
cramping. Leveled liver
enzymes and medicationinduced hepatitis or
pancreatitis can occur and be
monitored for.
Drug-Drug Interaction:
Lipitor can enhance the effect
of Coumadin and Digoxin
causing the patient to become
toxic and lead to death.
Drug-Food Interaction:
Rhabdomyolysis can occur
Page 11
General Cost
of
Therapeutic
Cost per
month is
$115.64 and
the cost per
dose is $3.85.
References
(Adams,
Holland, &
Urban, 2014)
(Cefalu, 2016)
(Fortney, 2012)
(Martin &
Talbert, 2013)
(Vallerand,
Sanoski, &
Deglin, 2015)
Anne Gonzalez
HMG-CoA Reductase
Inhibitors
inhibiting myocardial
infarction and cerebral
accidents.
Page 12
General Cost
of
Therapeutic
Cost of
medication
per month is
$5.00 and per
dose $0.16.
References
Adams,
Holland, &
Urban, 2014)
(Cefalu, 2016)
(Fortney, 2012)
(Martin &
Talbert, 2013)
(Vallerand,
Sanoski, &
Deglin, 2015)
Anne Gonzalez
General Mechanism of
Action: ASA will
prevent micro clots from
forming in capillaries
from abnormal epithelial
cell formation for
hyperglycemia. The
mechanism of ASA will
inhibit platelets from
aggregating creating
blockages in the vascular
system.
medication
Outline potential
contraindication for the
therapy: Individuals with
liver disease should not be
started on lovastatin.
Discontinue if muscle
weakness or cramping occurs
to prevent rhabdomyolysis.
Specific Indication for Outline patient safety issues
this patient population: associated with this therapy
The morphology of
Adverse Reactions:
platelets changes when
Individuals with a history of
the patient becomes
gastrointestinal bleeding or
diabetic. A daily dose of ulcers should use ASA with
ASA will help in
caution. Inappropriate use of
preventing
ASA can lead to GI bleeding,
microvascular
liver disease and renal disease.
complications in organ
Drug-drug interaction:
systems of the body.
There is an increase risk of
bleeding with combining ASA
in dual therapy with Plavix,
Heparin and Effient.
Drug-food interaction:
Foods that can cause increase
risk of bleeding is garlic and
ginger. Herbal supplements
that can cause bleeding are
chamomile, clove, and
feverfew.
Outline potential
Page 13
General Cost
of
Therapeutic
References
Adams,
Holland, &
Urban, 2014)
(Cefalu, 2016)
Anne Gonzalez
General Mechanism of
Action
Massage is a
combination of touch
and applied pressure to
the muscles and soft
tissues of the body. It
will decrease tension and
allow the body to relax
to allow blood to flow
freely.
General Mechanism of
Action:
Essential oils work on
the olfactory gland of the
Adverse Reaction:
Allergic reactions to products
used such as essential oils.
Injury from too much pressure
or discomfort.
Drug-Drug Interaction:
N/A
Drug-Food Interaction:
N/A
Outline potential
contraindication for the
therapy: Massage is not for
all patients. Some patients do
not enjoy the sensation of
touch from strangers. Injury
can occur from a non-licensed
individual performing the
massage.
Adverse Reaction: A skin
reaction to the oil can occur.
Redness or hives can be
presented and should be
Page 14
General Cost
of
Therapeutic
Range from
$40 to $100
per session
(Cefalu, 2016)
General Cost
of
Therapeutic
Vial $10.00 to
(Cefalu, 2016)
(Nahas, 2012)
(Nahas, 2012)
Anne Gonzalez
Daily Dosing: As
needed
Maintenance Dose:
Daily use to create the
calming effect desired.
13. Personal
Trainer/Physical
Fitness Expert
Route: Physical
Safe Dose: Twice a day
for one hour
Daily Dosing: Daily
for 45 minutes to one
hour
Maintenance Dose:
Three times a week for
one hour
General Mechanism of
Action:
Physical activity will
increase the heart rate
and motivate the body to
burn stored energy to
meet the demand of the
body to burn calories.
14. Yoga
Route: Physical
movement
Safe Dose: Three times
General Mechanism of
Action: Purposeful
movements that stretch
and use all muscles of
$25.00
depending on
the oil
purchased
General Cost
of
Therapeutic
Page 15
General Cost
of
Therapeutic
Per session
$25 to $40
(Anderson,
2014)
(Cefalu, 2016)
(Nahas, 2012)
(Anderson,
2014)
(Cefalu, 2016)
Anne Gonzalez
a week or daily
Daily Dosing: 30
minutes to two hours
Maintenance Dose:
Ideally daily for
physical and mental
wellbeing
General Mechanism of
Action: Participants are
guided on how to quit
smoking with will power
and knowledge. Patients
are taught healthy
techniques to stop the
oral fixation of smoking.
Page 16
Per class
$9.00
(Nahas, 2012)
General Cost
of
Therapeutic
Programs can
vary form $35
to $100 for
four weeks.
(Anderson,
2014)
(Cefalu, 2016)
(Nahas, 2012)
Anne Gonzalez
Summary of application of holistic therapeutics to health of chosen population and expected optimal outcomes of care:
The five integrative therapies chosen for this population are massage, essential oil therapy, personal trainer, yoga, and smoking cessation. T2D
is ultimately triggered from lifestyle habits of physical inactivity, stress, and poor dietary decisions (Cefalu, 2016). Taking control of ones life and
becoming active with a fitness expert to establish an exercise routine is crucial. A fitness expert has valuable knowledge on meal planning and can
help establish a healthy diet. Networking with fitness experts will help the diabetic patient develop a support team and a motivator to help the
participant push ones self to over come challenges and obstacles. Stress management with yoga, essential oils, and massage will help prevent
depression and anxiety (Fortney, 2012). Uncontrolled emotions can lead to over eating and making wrong lifestyle choices. Smoking is dangerous for
everyone but in a diabetic patient it accelerates the growth of vascular complications (Cefalu, 2016). Learning to cope with stress will decrease the
participants need to smoke and help to prevent poor food selections. These integrative therapies are essential to becoming healthy and will work well
with the medications ordered by the primary care provider.
Reference
Page 17
Anne Gonzalez
Adams, M. P., Holland, L. N., & Urban, C. Q. (2014). Pharmacology for nurses: A pathophysiologic approach (4th ed.). Retrieved from
https://online-statref-com.ezproxy1.library.arizona.edu/Document.aspx?FxId=198&SessionID=227ED2BGKLPKMXNB
Anderson, J. (2014). Healthy coaching: A partnership on the journey to wellbeing. In M. Kreitzer, & M. Koithan (Eds.), Integrative nursing (pp. 171183). New York, NY: Oxford University Press.
Bagheri-Nesami, M., Shorofi, S. A., Nikkhah, A., Espahbodi, F., & Koolaee, F. (2016). The effects of aromatherapy with lavender essential oil on
fatigue levels in hemodialysis patients: A randomized clinical trial. Complementary Therapies in Clinical Practice, 22, 33-37.
http://dx.doi.org/10.1016/j.ctcp.2015.12.002
Cefalu, W. T. (Ed.). (2016). Standards of medical care in diabetes-2016 [Entire issue]. Diabetes Care, 39(1). http://dx.doi.org/10.2337/dc16-S004
Centers for Disease Control and Prevention. (2014). National diabetes statistics report, 2014 [Press release]. Retrieved from :
http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf
Faison, Y., Burns, D., & Weed, D. (2016). Application of Ferrans and Power quality of life model to improve diabetes health outcomes . Holistic
Nursing Practice, 30(3), 131-138. http://dx.doi.org/10.1097/HNP.0000000000000149
Fortney, L. (2012). Recommending meditation. In D. Rakel (Ed.), Integrative medicine (3rd ed., pp. 873-881). Retrieved from https://wwwclinicalkey-com.ezproxy2.library.arizona.edu/#!/content/book/3-s2.0-B9781437717938000820
Gardiner, P., & Low Dog, T. (2012). Prescribing botanicals. In D. Rakel (Ed.), Integrative medicine (3rd ed., pp. 913-921). [Arizona Health Science
Library]. Retrieved from https://www-clinicalkey-com.ezproxy2.library.arizona.edu/#!/content/book/3-s2.0-B978143771793800087X
Page 18
Anne Gonzalez
Joy, M. S. (2013). Genomics and the kidney. In J. S. Bertino, C. DeVane, U. Fuhr, A. D. Kashuba, & J. D. Ma (Eds.), Pharmacogenomics: An
introduction and clinical perspective. Retrieved from http://accesspharmacy.mhmedical.com.ezproxy4.library.arizona.edu/content.aspx?
bookid=511§ionid=40849387
Martin, C. P., & Talbert, R. L. (2013). Pharmacotherapy: Bedside guide. Retrieved from Arizona Health Science Library
Nahas, R. (2012). Type 2 Diabetes. In D. Rakel (Ed.), Integrative medicien (3rd ed., pp. 297-311). Retrieved from https://www-clinicalkeycom.ezproxy4.library.arizona.edu/#!/content/book/3-s2.0-B9781437717938000327
Olokoba, A. B., Obateru, O. A., & Olokoba, L. B. (2012). Type 2 diabetes mellitus: A review of current trends. Oman Medical Journal , 27(4), 269273. http://dx.doi.org/10. 5001/omj.2012.68
Potter, L., Wallston, K., Trief, P., Juth, V., & Smyth, J. (2015). Attributing discrimination to weight: Associations with well-being, self-care, and
disease status in patients with type two diabetes mellitus. Journal of Behavioral Medicine , 38(6), 863-875. http://dx.doi.org/10.1007/s10865015-9655-0
Vallerand, A. H., Sanoski, C. A., & Deglin, J. H. (2015). Davis drug guide for nurses (14th ed.). Retrieved from https://online-statrefcom.ezproxy1.library.arizona.edu/Document.aspx?
FxId=58&SessionID=227ED2BGKLPKMXNB#H&1&ChaptersTab&N6Gco_9BBDOQaaQ0KDh78Q%3d%3d&&58
Page 19